These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29935205)

  • 1. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
    J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
    Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
    McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
    Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
    McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
    Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
    Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
    Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
    VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
    J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
    McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
    J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A; Franco MA; Charpilienne A; Cohen J; Pothier P; Kohli E
    Eur J Immunol; 2005 Jul; 35(7):2122-30. PubMed ID: 15948217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccination and infection induce VP6-specific IgA responses.
    Lappalainen S; Blazevic V; Malm M; Vesikari T
    J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Knowlton DR; McNeal MM; Ward RL
    Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity induced by rotavirus DNA vaccines.
    Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
    Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
    Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
    J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.